Clinical Trials Browser

Mesothelioma, Malignant × Imprint II × 90 days × Clear all

NCT04897022 2026-03-12

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant